Bacterial cell wall component or protein (null)

The bacterial cell wall is a complex, rigid structure external to the plasma membrane, primarily composed of **peptidoglycan** in both Gram-positive and Gram-negative bacteria, and complemented by secondary polymers including **teichoic acid** (in Gram-positives) and **lipopolysaccharide** (in Gram-negatives)[5][2][1][4][7]. This structure is vital for **cell shape**, **structural integrity**, **osmotic protection**, and serves as a major determinant of **bacterial virulence**, immune recognition, and survival under environmental stresses[1][3][5]. Its unique components, absent in human cells, make the cell wall and associated proteins attractive **drug targets** for antibiotics and biologics[2][5][6][8]. Numerous drug classes, such as beta-lactams, glycopeptides, and monoclonal antibodies, exert their effects by disrupting cell wall biosynthesis, structurally damaging the wall, or neutralizing associated toxins[6][4][5][2]. However, cell wall targeting can trigger host inflammatory responses (endotoxin shock) and rapid resistance development is a significant therapeutic challenge[4][6][2]. Individual molecular targets within the wall should be specified for structured reporting.

Other names

Bacterial cell wallPeptidoglycan (PG)Wall teichoic acid (WTA)Penicillin-binding proteins (PBPs)Lipopolysaccharide (LPS)Capsule polysaccharide

Inhibition of cell wall synthesis or polymerization (e.g., blocking peptidoglycan crosslinking or assembly) Disruption of structural integrity (lysis via hydrolytic enzymes or antibodies) Neutralization of cell wall-associated toxins (e.g., mAbs neutralizing anthrax toxin or C. difficile toxin) Interference with cell wall maintenance (e.g., inhibition of biosynthetic enzymes or pathway proteins)